Abstract

The use of ketorolac may reduce opioid exposure in infants less than 6 months of age undergoing congenital heart surgery

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call